Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Paula Helena Sieber und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany. Hauptthemen laut MEDLINE: Serum Albumin, Human, Disulfides, Acetylcysteine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation (DFG), Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Malodorants comprise notoriously smelling mercaptans and might be applied for crowd control. Because exposure to malodorants may lead to irritation of the respiratory system, choking, and coma, bioanalytical verification of poisoning might be required in a medical and forensic context. We herein present the detection and identification of novel biomarkers of exposure to ethyl mercaptan, n ‐butyl mercaptan, tert ‐butyl mercaptan, and iso ‐amyl mercaptan. These alkyl thiol compounds were found to form disulfide adducts in human serum albumin (HSA) in plasma in vitro with the only non‐disulfide‐bridged Cys 34 residue and with other residues being part of the disulfide‐bridged pattern in HSA. After proteinase K‐catalyzed proteolysis, adducts of all mercaptans were detected simultaneously as the tripeptide Cys 34 *ProPhe and the dipeptides Cys 369 *Tyr, ValCys 316 *, and Cys x *Ala (x denominates either Positions 91, 200, 253, 361, and/or 448) by a sensitive micro‐liquid chromatography–electrospray ionization tandem mass spectrometry (μLC‐ESI MS/MS) method working in the scheduled multiple reaction monitoring (sMRM) mode. Time‐ and concentration‐dependent adduct formations while exposure and proteolysis were investigated and the suitability of adducts as biomarkers of exposure was elaborated. Adducts at Cys 34 showed the lowest limits of identification (LOIs, 6 nM to 1.2 μM mercaptan in plasma) and superior stability in plasma at 37°C. Therefore, Cys 34 *ProPhe appears as the most promising target to prove exposure to mercaptans at least in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
- Walther-Straub-Institute of Pharmacology and Toxicology, LMU Munich, Munich, Germany.
ORCID-Profile: Paula Helena Sieber, Harald John
Förderung
- German Research Foundation (DFG)
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Sieber, P. H., Steinritz, D., Worek, F., & John, H. (2025). Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro. Drug Testing and Analysis. https://doi.org/10.1002/dta.3776
Vancouver
Sieber PH, Steinritz D, Worek F, John H. Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro. Drug Testing and Analysis. 2025. doi:10.1002/dta.3776
BibTeX
@article{Sieber2025,
author = {Sieber, Paula Helena and Steinritz, Dirk and Worek, Franz and John, Harald},
title = {Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3776}
}
EUVIMED